BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

797 related articles for article (PubMed ID: 17451928)

  • 1. Characterization of the film formation of the dry coating process.
    Kablitz CD; Urbanetz NA
    Eur J Pharm Biopharm; 2007 Sep; 67(2):449-57. PubMed ID: 17451928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dry coating in a rotary fluid bed.
    Kablitz CD; Harder K; Urbanetz NA
    Eur J Pharm Sci; 2006 Feb; 27(2-3):212-9. PubMed ID: 16290285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.
    Sauer D; Zheng W; Coots LB; McGinity JW
    Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimised process and formulation conditions for extended release dry polymer powder-coated pellets.
    Terebesi I; Bodmeier R
    Eur J Pharm Biopharm; 2010 May; 75(1):63-70. PubMed ID: 20079833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained release coating of tablets with Eudragit(®) RS/RL using a novel electrostatic dry powder coating process.
    Qiao M; Luo Y; Zhang L; Ma Y; Stephenson TS; Zhu J
    Int J Pharm; 2010 Oct; 399(1-2):37-43. PubMed ID: 20678560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parameters influencing polymer particle layering of the dry coating process.
    Kablitz CD; Kappl M; Urbanetz NA
    Eur J Pharm Biopharm; 2008 Jun; 69(2):760-8. PubMed ID: 18434111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating the process parameters of the dry coating process using a 2(5-1) factorial design.
    Kablitz CD; Urbanetz NA
    Pharm Dev Technol; 2013 Feb; 18(1):39-45. PubMed ID: 21851294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymer blends used for the aqueous coating of solid dosage forms: importance of the type of plasticizer.
    Lecomte F; Siepmann J; Walther M; MacRae RJ; Bodmeier R
    J Control Release; 2004 Sep; 99(1):1-13. PubMed ID: 15342176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel electrostatic dry coating process for enteric coating of tablets with Eudragit® L 100-55.
    Qiao M; Zhang L; Ma Y; Zhu J; Xiao W
    Eur J Pharm Biopharm; 2013 Feb; 83(2):293-300. PubMed ID: 23183445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between drug dissolution and leaching of plasticizer for pellets coated with an aqueous Eudragit S100:L100 dispersion.
    Bando H; McGinity JW
    Int J Pharm; 2006 Oct; 323(1-2):11-7. PubMed ID: 16815652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
    Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
    Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Properties of melt extruded enteric matrix pellets.
    Schilling SU; Shah NH; Waseem Malick A; McGinity JW
    Eur J Pharm Biopharm; 2010 Feb; 74(2):352-61. PubMed ID: 19782133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel powder coating process for attaining taste masking and moisture protective films applied to tablets.
    Cerea M; Zheng W; Young CR; McGinity JW
    Int J Pharm; 2004 Jul; 279(1-2):127-39. PubMed ID: 15234801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applying a novel electrostatic dry powder coating technology to pellets.
    Yang Q; Ma Y; Zhu J
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):118-24. PubMed ID: 26478275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of additives on melt viscosity, surface tension, and film formation of dry powder coatings.
    Sauer D; McGinity JW
    Drug Dev Ind Pharm; 2009 Jun; 35(6):646-54. PubMed ID: 19337869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of poly(styrene-alt-maleic anhydride)-ethanol as enteric coating material.
    Lai X; Sun C; Tian H; Zhao W; Gao L
    Int J Pharm; 2008 Mar; 352(1-2):66-73. PubMed ID: 18054184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of capillary force promoters in dry coating procedures--evaluation of acetylated monoglyceride, isopropyl myristate and palmitate.
    Klar F; Urbanetz NA
    Eur J Pharm Biopharm; 2009 Jan; 71(1):124-9. PubMed ID: 18684399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coating of pellets with micronized ethylcellulose particles by a dry powder coating technique.
    Pearnchob N; Bodmeier R
    Int J Pharm; 2003 Dec; 268(1-2):1-11. PubMed ID: 14643971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dry powder coating of pellets with micronized Eudragit RS for extended drug release.
    Pearnchob N; Bodmeier R
    Pharm Res; 2003 Dec; 20(12):1970-6. PubMed ID: 14725361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel approach for dry powder coating of pellets with Ethylcellulose. Part I: Evaluation of film formulation and process set up.
    Albertini B; Bertoni S; Melegari C; Dolci LS; Passerini N
    Int J Pharm; 2017 Jan; 516(1-2):380-391. PubMed ID: 27894987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.